Showing 1 to 12 of 18 results
Rising STIs in Hesse Spur Public Health Response
Reported cases of syphilis and gonorrhea are rising in Hesse, Germany, prompting increased preventative efforts and public awareness campaigns focusing on HPV vaccination and accessible STI testing, especially in underserved rural areas.
Rising STIs in Hesse Spur Public Health Response
Reported cases of syphilis and gonorrhea are rising in Hesse, Germany, prompting increased preventative efforts and public awareness campaigns focusing on HPV vaccination and accessible STI testing, especially in underserved rural areas.
Progress
24% Bias Score
Preventing Oral Cancer: Risk Factors and Early Detection Methods
Oral cancer ranks 13th globally but is highly preventable. Professor Irina Makeeva identifies key risk factors: tobacco, alcohol, trauma from ill-fitting dentures, oncogenic HPV strains, and galvanic currents from metal crowns. Early detection via visual inspection and fluorescence diagnostics is cr...
Preventing Oral Cancer: Risk Factors and Early Detection Methods
Oral cancer ranks 13th globally but is highly preventable. Professor Irina Makeeva identifies key risk factors: tobacco, alcohol, trauma from ill-fitting dentures, oncogenic HPV strains, and galvanic currents from metal crowns. Early detection via visual inspection and fluorescence diagnostics is cr...
Progress
12% Bias Score
England Extends Cervical Cancer Screening Interval to Five Years
Starting July, England will screen women aged 25-49 for cervical cancer every five years instead of three, impacting up to seven million people, based on UK National Screening Committee recommendations and studies showing similar cancer detection rates with less frequent testing.
England Extends Cervical Cancer Screening Interval to Five Years
Starting July, England will screen women aged 25-49 for cervical cancer every five years instead of three, impacting up to seven million people, based on UK National Screening Committee recommendations and studies showing similar cancer detection rates with less frequent testing.
Progress
36% Bias Score
HPV, Cervical Cancer Prevention, and Early Detection
Cervical cancer, primarily caused by HPV, is preventable through vaccination (recommended for ages 9-14), regular Pap tests and HPV tests (starting at age 21), and safe sex practices; early detection significantly improves treatment outcomes.
HPV, Cervical Cancer Prevention, and Early Detection
Cervical cancer, primarily caused by HPV, is preventable through vaccination (recommended for ages 9-14), regular Pap tests and HPV tests (starting at age 21), and safe sex practices; early detection significantly improves treatment outcomes.
Progress
16% Bias Score
FDA Approves At-Home Cervical Cancer Test
The FDA approved Teal Health's at-home cervical cancer test, the Teal Wand, a 96% accurate self-collection device designed to increase screening rates and potentially reduce the 4,000 annual U.S. deaths from cervical cancer by detecting HPV, the virus responsible for almost all cases.
FDA Approves At-Home Cervical Cancer Test
The FDA approved Teal Health's at-home cervical cancer test, the Teal Wand, a 96% accurate self-collection device designed to increase screening rates and potentially reduce the 4,000 annual U.S. deaths from cervical cancer by detecting HPV, the virus responsible for almost all cases.
Progress
36% Bias Score
Anal Cancer Cases Rise Sharply Among Older Women in US
A new study reveals a sharp increase in US anal cancer cases among women over 65, particularly white women (4% annual increase), challenging traditional high-risk group assumptions and highlighting the need for expanded HPV vaccination and screening.
Anal Cancer Cases Rise Sharply Among Older Women in US
A new study reveals a sharp increase in US anal cancer cases among women over 65, particularly white women (4% annual increase), challenging traditional high-risk group assumptions and highlighting the need for expanded HPV vaccination and screening.
Progress
48% Bias Score
HPV Linked to Squamous Cell Carcinoma
Researchers at the National Institutes of Health (NIH) have linked human papillomavirus (HPV), a common sexually transmitted disease, to squamous cell carcinoma, the second most common skin cancer in the US, after studying a 34-year-old woman whose recurrent skin cancer was found to have HPV integra...
HPV Linked to Squamous Cell Carcinoma
Researchers at the National Institutes of Health (NIH) have linked human papillomavirus (HPV), a common sexually transmitted disease, to squamous cell carcinoma, the second most common skin cancer in the US, after studying a 34-year-old woman whose recurrent skin cancer was found to have HPV integra...
Progress
44% Bias Score
France Extends HPV Vaccination Catch-Up to Age 26
France's CTV recommends extending HPV vaccination catch-up to age 26, aiming to prevent 6,400 annual HPV-related cancers; the vaccine's near 100% effectiveness before age 17 highlights its crucial role in public health.
France Extends HPV Vaccination Catch-Up to Age 26
France's CTV recommends extending HPV vaccination catch-up to age 26, aiming to prevent 6,400 annual HPV-related cancers; the vaccine's near 100% effectiveness before age 17 highlights its crucial role in public health.
Progress
60% Bias Score
FDA-Approved At-Home Cervical Cancer Test Aims to Increase Early Detection
A new at-home cervical cancer screening test, approved by the FDA, offers a convenient and less invasive alternative to traditional methods, potentially increasing early detection rates and reducing mortality in California, with plans for nationwide rollout.
FDA-Approved At-Home Cervical Cancer Test Aims to Increase Early Detection
A new at-home cervical cancer screening test, approved by the FDA, offers a convenient and less invasive alternative to traditional methods, potentially increasing early detection rates and reducing mortality in California, with plans for nationwide rollout.
Progress
60% Bias Score
France Expands HPV Vaccination to Age 26
France's health authority recommends expanding HPV vaccination catch-up to all individuals up to age 26, aiming to increase vaccination coverage and reduce HPV-related cancers, although vaccination between 11 and 14 years old remains prioritized.
France Expands HPV Vaccination to Age 26
France's health authority recommends expanding HPV vaccination catch-up to all individuals up to age 26, aiming to increase vaccination coverage and reduce HPV-related cancers, although vaccination between 11 and 14 years old remains prioritized.
Progress
8% Bias Score
FDA Approves First At-Home Cervical Cancer Screening Device
The FDA approved Teal Wand, an at-home self-collection device for cervical cancer screening, allowing women to collect samples at home and mail them for HPV testing using Roche's test, aiming to increase screening rates and improve outcomes.
FDA Approves First At-Home Cervical Cancer Screening Device
The FDA approved Teal Wand, an at-home self-collection device for cervical cancer screening, allowing women to collect samples at home and mail them for HPV testing using Roche's test, aiming to increase screening rates and improve outcomes.
Progress
36% Bias Score
AI Chatbot Significantly Boosts HPV Vaccination Rates in China
A study in China found that parents using an AI chatbot to learn about the HPV vaccine were three times more likely to vaccinate their children, with an eight-fold increase in rural areas; this improved vaccine literacy and consultations with healthcare workers.
AI Chatbot Significantly Boosts HPV Vaccination Rates in China
A study in China found that parents using an AI chatbot to learn about the HPV vaccine were three times more likely to vaccinate their children, with an eight-fold increase in rural areas; this improved vaccine literacy and consultations with healthcare workers.
Progress
56% Bias Score
Showing 1 to 12 of 18 results